Safety and efficacy of peginterferon Alfa-2a and ribavirin for hepatitis C in thalassemia.

被引：0
|
作者：
Harmatz, Paul
Olivieri, Nancy F.
Kwiatkowski, Janet
Vichinsky, Elliott
Giardina, Patricia
Shah, Farrukh
Wright, Elizabeth C.
Fischer, Roland
Jonas, Maureen M.
机构：
[1] Childrens Hosp, Oakland, CA 94609 USA
[2] Univ Hlth Network, Toronto, ON, Canada
[3] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[4] Cornell Univ, Weill Med Coll, New York, NY USA
[5] UCL, London, England
[6] New England Res Inst, Watertown, MA 02172 USA
[7] Childrens Hosp, Boston, MA 02115 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.558.558
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
558
引用
收藏
页码：168A / 168A
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Peginterferon Alfa-2a and Ribavirin Treatment of Chronic Hepatitis C in the Republic of Serbia
    Bozic, Milena
    Bojovic, Ksenija
    Fabri, Milotka
    Nozic, Darko
    Trkulja, Bojan
    Milosevic, Ivana
    [J]. SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2012, 140 (7-8) : 448 - 455
  • [2] Chronic hepatitis C genotype 4:: Efficacy and safety of the treatment with peginterferon alfa-2a plus ribavirin
    Diago, M.
    Boadas, J.
    Planas, R.
    Sola, R.
    del Olmo, J. A.
    Crespo, J.
    Erdozain, J. C.
    Anton, M. D.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S292 - S292
  • [3] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Hepatitis C
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (18): : 1808 - 1809
  • [4] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C
    Rakov, NE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03): : 259 - 260
  • [5] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Hepatitis C REPLY
    Albrecht, Janice
    McHutchison, John
    Sulkowski, Mark
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (18): : 1809 - 1809
  • [6] Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin
    Rustgi, V. K.
    Esposito, S.
    Hamzeh, F. M.
    Shiffman, M. L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (05) : 433 - 440
  • [7] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C - Reply
    Fried, MW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03): : 260 - 260
  • [8] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
    McHutchison, John G.
    Lawitz, Eric J.
    Shiffman, Mitchell L.
    Muir, Andrew J.
    Galler, Greg W.
    McCone, Jonathan
    Nyberg, Lisa M.
    Lee, William M.
    Ghalib, Reem H.
    Schiff, Eugene R.
    Galati, Joseph S.
    Bacon, Bruce R.
    Davis, Mitchell N.
    Mukhopadhyay, Pabak
    Koury, Kenneth
    Noviello, Stephanie
    Pedicone, Lisa D.
    Brass, Clifford A.
    Albrecht, Janice K.
    Sulkowski, Mark S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (06): : 580 - 593
  • [9] Low dose peginterferon alfa-2a and ribavirin for chronic hepatitis C, genotype 2 & 3: Viral kinetics, efficacy and safety
    Rotman, Yaron
    Borg, Brian B.
    Soza, Alejandro
    Loomba, Rohit
    Modi, Apurva A.
    Feld, Jordan J.
    Rivera, Elenito
    Doo, Edward
    Heller, Theo
    Ghany, Marc
    Neumann, Avidan U.
    Liang, T. Jake
    Hoofnagle, Jay H.
    [J]. HEPATOLOGY, 2007, 46 (04) : 383A - 383A
  • [10] Interim analysis of the safety and efficacy of peginterferon alfa-2a plus ribavirin in chronic hepatitis C patients unable to tolerate or nonresponsive to treatment with peginterferon alfa-2b plus ribavirin
    Rustgi, VK
    Esposito, S
    Freilich, B
    Lopez-Talavera, JC
    Lentz, E
    Shiffman, ML
    [J]. HEPATOLOGY, 2005, 42 (04) : 692A - 692A
12345